Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Respir Res ; 20(1): 267, 2019 Dec 18.
Artigo em Inglês | MEDLINE | ID: mdl-31847850

RESUMO

INTRODUCTION: Bacteria have been extensively implicated in the development of smoking related diseases, such as COPD, by either direct infection or bacteria-mediated inflammation. In response to the health risks associated with tobacco exposure, the use of electronic cigarettes (e-cigs) has increased. This study compared the effect of e-cig vapour (ECV) and cigarette smoke (CSE) on the virulence and inflammatory potential of key lung pathogens (Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus and Pseudomonas aeruginosa). METHODS: Biofilm formation, virulence in the Galleria mellonella infection model, antibiotic susceptibility and IL-8/TNF-α production in A549 cells, were compared between bacteria exposed to ECV, CSE and non-exposed bacteria. RESULTS: Statistically significant increases in biofilm and cytokine secretion were observed following bacterial exposure to either ECV or CSE, compared to non-exposed bacteria; the effect of exposure to ECV on bacterial phenotype and virulence was comparable, and in some cases greater, than that observed following CSE exposure. Treatment of A549 cells with cell signaling pathway inhibitors prior to infection, did not suggest that alternative signaling pathways were being activated following exposure of bacteria to either ECV or CSE. CONCLUSIONS: These findings therefore suggest that ECV and CSE can induce changes in phenotype and virulence of key lung pathogens, which may increase bacterial persistence and inflammatory potential.


Assuntos
Biofilmes/efeitos dos fármacos , Vapor do Cigarro Eletrônico/toxicidade , Haemophilus influenzae/efeitos dos fármacos , Pulmão/efeitos dos fármacos , Nicotiana/efeitos adversos , Pneumonia Bacteriana/induzido quimicamente , Pseudomonas aeruginosa/efeitos dos fármacos , Fumaça/efeitos adversos , Staphylococcus aureus/efeitos dos fármacos , Streptococcus pneumoniae/efeitos dos fármacos , Células A549 , Animais , Biofilmes/crescimento & desenvolvimento , Haemophilus influenzae/crescimento & desenvolvimento , Haemophilus influenzae/patogenicidade , Humanos , Mediadores da Inflamação/metabolismo , Interleucina-8/metabolismo , Larva/microbiologia , Pulmão/metabolismo , Pulmão/microbiologia , Mariposas/embriologia , Mariposas/microbiologia , Pneumonia Bacteriana/metabolismo , Pneumonia Bacteriana/microbiologia , Pseudomonas aeruginosa/crescimento & desenvolvimento , Pseudomonas aeruginosa/patogenicidade , Staphylococcus aureus/crescimento & desenvolvimento , Staphylococcus aureus/patogenicidade , Streptococcus pneumoniae/crescimento & desenvolvimento , Streptococcus pneumoniae/patogenicidade , Fator de Necrose Tumoral alfa/metabolismo , Virulência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA